GeneralNeutralBlockonomi · 4h ago5/10
📰
Hims & Hers Health (HIMS) Q1 Earnings Preview: What Investors Need to Know
Hims & Hers (HIMS) reports Q1 earnings with analysts expecting minimal revenue growth and low earnings per share as the company transitions its business model toward Novo Nordisk products. This pivot represents a significant strategic shift that could reshape investor expectations around profitability and market positioning.